|
|
Volumn 63, Issue 5, 2002, Pages 294-297
|
|
Advances in the medical management of rheumatoid arthritis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN G;
INFLIXIMAB;
ISOXAZOLE DERIVATIVE;
LEFLUNOMIDE;
METHOTREXATE;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
SALAZOSULFAPYRIDINE;
STEROID;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
DRUG COMBINATION;
HUMAN;
REVIEW;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG THERAPY, COMBINATION;
HUMANS;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN G;
ISOXAZOLES;
METHOTREXATE;
RECEPTORS, TUMOR NECROSIS FACTOR;
STEROIDS;
SULFASALAZINE;
TREATMENT OUTCOME;
|
|
EID: 0036560548
PISSN: 14623935
EISSN: None
Source Type: Journal
DOI: 10.12968/hosp.2002.63.5.2023 Document Type: Review |
|
Times cited : (2)
|
|
References (25)
|
